A broad range of molecular and cellular interactions contribute to various pathophysiological alterations in haemostasis. Recent studies have shown strong links between lipoproteins and coagulation factors. Findings suggest that lipoproteins play an important role in the fibrinolytic and thrombogenic mechanisms that influence the risks of patients in acute coronary syndromes. We will examine specific aspects of lipoproteins with reference to the effects of hyperlipidaemia on endothelial dysfunction and haemostasis, and its relevance in the patient presenting for revascularization.
Get full access to this article
View all access options for this article.
References
1.
Campbell FW , Jobes DR , Ellison N.Coagulation management during and after cardiopulmonary bypass. In: Hensley FA , Martin DE eds. A practical approach to cardiac anesthesia, 2nd edition. Boston, MA: Little, Brown , 1995: 434-463.
Ferraris VA , Ferraris SP.Limiting excessive postoperative blood transfusion after cardiac procedures: a review . Tex Heart Inst J1995; 22: 216-230 .
4.
Penta de Peppo A , Pierri MD , Scafuri Aet al.Intraoperative antifibrinolysis and blood-saving techniques in cardiac surgery: prospective trial of three antifibrinolytic drugs . Tex Heart Inst J1995; 22: 231-236 .
5.
Hunt BJ.The relation between abnormal hemostatic function and the progression of coronary disease . Curr Opin Cardiol1990; 5: 758-765 .
Fuster V.Elucidation of the role of plaque instability and rupture in acute coronary events . Am J Cardiol1995; 76: 24C-33C .
9.
Navab M , Folgelman AM , Berliner JAet al.Pathogenesis of atherosclerosis . Am J Cardiol1995; 76: 18C-24C .
10.
Mitropoulos KA.Lipid-thrombosis interface . Br Med Bull1994; 50: 813-832 .
11.
Genest J , Cohn JS.Clustering of cardiovascular risk factors: targeting high-risk individuals . Am J Cardiol1995; 76: 8A-20A .
12.
Kinlay S , Selwyn AP , Delagrange D , Creager MA , Libby P , Ganz P.Biological mechanisms for the clinical success of lipid-lowering in coronary artery disease and the use of surrogate end-points . Curr Opin Lipidol1996; 7: 389-397 .
Kottke-Marchant K.Laboratory diagnosis of hemorrhagic and thrombotic disorders . Hematol Oncol Clin North Am1994; 8: 809-853 .
15.
Sala N , Fontcuberta J , Rutllant ML.New biological concepts on coagulation inhibitors . Int Care Med1993; 19: S3-S7 .
16.
Willerson JT.Conversion from chronic to acute coronary heart disease syndromes . Tex Heart Inst J1995; 22: 13-19 .
17.
Warkentin TE.Hemostasis and atherosclerosis . Can J Cardiol; 11: 29C-34C .
18.
Juhan-Vague I.Hemostasis risk factors in cardiovascular disease [Abstract] . XII international symposium on drugs affecting lipid metabolism. Houston, TX, 1995.
19.
Luchtman-Jones L , Broze GC.The current status of coagulation . Ann Med1995; 27: 47-52 .
20.
Guyton AC.Textbook of medical physiology, 6th edition. Philadelphia, PA: WB Saunders , 1981: 876-876.
Ballantyne CM , Chan L , Guevara Jet al.Recent advances in lipoprotein and atherosclerosis research at Baylor College of Medicine . Tex Heart Inst J1994; 21: 48-55 .
Hajjar KA , Gavish D , Breslow JL , Nachman RL.Lipoprotein(a) modulation of endothelial cell surface fibrinolysis and its potential role in atherosclerosis . Nature1989; 339: 303-305 .
25.
Rabbini LE , Loscalzo J.Recent observations on the role of hemostatic determinants in the development of the atherothrombotic plaque . Atheroscl1995; 105: 1-7 .
26.
Johansson J , Egberg N , Johnsson H , Carlson LA.Serum lipoproteins and hemostatic function in intermittent claudication . Arterioscler Thromb1993; 13: 1441-1448 .
27.
Holme I.Cholesterol reduction and its impact on coronary artery disease and total mortality . Am J Cardiol1995; 76: 10C-17C .
28.
Gotto AM.Lipid risk factors and the regression of atherosclerosis . Am J Cardiol1995; 76: 3A-7A .
29.
Reaven GM.Role of insulin resistance in human disease (syndrome X): an expanded definition . Annu Rev Med1993; 44: 121-131 .
30.
Daae Ln , Kierulf P , Lanndaas S , Urdal P.Cardiovascular risk factors: interactive effects of lipids, coagulation and fibrinolysis . Scand J Clin Lab Invest1993; 53: 19-27 .
Christenson JT , Gras PA , Grosclaude Aet al.Reactive thrombocytosis following coronary artery bypass surgery: a possible link to a lipid dysfunction . J Cardiovasc Surg1996; 37: 491-498 .
33.
Boyle EM , Verrier ED , Spiess BD.Endothelial cell injury in cardiovascular surgery: the procoagulant response . Ann Thorac Surg1996; 62: 1549-1557 .
34.
Gordon BR , Saal SD.Current status of low density lipoprotein-apheresis for the therapy of severe hyperlipidemia . Curr Opin Lipidol1996; 7: 381-384 .
35.
Daida H , Young JL , Yokoi Het al.Prevention of restenosis after percutaneous transluminal coronary angioplasty by reducing lipoprotein(a) levels with low-density lipoprotein apheresis . Am J Cardiol1994; 73: 1037-1040 .
36.
Hamsten A , Karpe F , Bavenholm P , Silveira A.Interactions amongst insulin, lipoproteins and hemostatic function relevant to coronary heart disease . J Int Med1994; 236: 75-88 .
